Reverb Therapeutics raised $12 million in a seed round led by Amplitude Ventures to advance its Amplify•R™ platform for treating life-threatening diseases.

Feb 19, 2025•10 months ago

Amount Raised

$12 Million

Round Type

seed

VancouverTherapeuticsBiotechnologyHealth Care

Investors

Seido CapitalIn Bc Investment Corp.Finchley Healthcare VenturesKd T VenturesMyeloma Investment FundAmplitude Ventures

Description

Reverb Therapeutics announced the closure of a $12 million financing round, with Amplitude Ventures leading the investment. The funding will support the development of its Amplify•R™ platform aimed at modulating cytokine actions to treat cancer and autoimmune diseases.

Company Information

Company

Reverb Therapeutics

Location

Vancouver, British Columbia, Canada

About

Reverb Therapeutics is a leader in creating precision medicine by harnessing the body’s immune system and endogenous cytokines. Their Amplify•R™ platform combines bispecific antibody engineering with data-driven modelling to amplify cytokine activity in a tissue-specific manner. This innovative approach aims to avoid the common hurdles associated with cytokine treatments while focusing on cancer and autoimmune diseases. Reverb's technology enables rapid pre-clinical testing and is scalable across multiple therapeutic areas.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends